Joon-Young Kim Selected Research

Dosage-sensitive sex reversal

5/2004

Differential role of the loop region between helices H6 and H7 within the orphan nuclear receptors small heterodimer partner and DAX-1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joon-Young Kim Research Topics

Disease

4	Vascular Calcification 01/2016 - 04/2010
3	Atherosclerosis 11/2015 - 04/2009
3	Vascular System Injuries 01/2014 - 04/2009
3	Hyperplasia 01/2014 - 10/2009
3	Neoplasms (Cancer) 01/2013 - 03/2007
2	Glaucoma 07/2021 - 01/2018
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2015 - 02/2012
2	Fibrosis (Cirrhosis) 02/2012 - 01/2012
2	Intervertebral Disc Displacement (Herniated Disc) 01/2010 - 07/2007
1	Blister (Bulla) 07/2021
1	Fistula 01/2021
1	Vascular Remodeling 01/2014
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2014
1	Vascular Diseases (Vascular Disease) 01/2014
1	Cerebral Palsy (Spastic Diplegia) 07/2013
1	Neonatal Jaundice 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 01/2013
1	Ureteral Obstruction 01/2012
1	Urolithiasis 05/2011
1	Hypercalciuria 05/2011
1	Infections 11/2010
1	Thrombosis (Thrombus) 11/2010
1	Type 2 Diabetes Mellitus (MODY) 04/2010
1	Back Pain (Backache) 01/2010
1	Carcinogenesis 10/2008
1	Body Weight (Weight, Body) 07/2004
1	Familial Hypoadrenocorticism 05/2004
1	Dosage-sensitive sex reversal 05/2004

Drug/Important Bio-Agent (IBA)

2	CollagenIBA 07/2021 - 01/2018
2	pyruvate dehydrogenase kinase 4IBA 01/2016 - 11/2015
2	Phosphates (Orthophosphate)IBA 11/2015 - 02/2012
2	quinone (benzoquinone)IBA 01/2014 - 04/2009
2	Oxidoreductases (Dehydrogenase)IBA 01/2014 - 04/2009
2	Dimethyl FumarateIBA 01/2014 - 01/2012
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2013 - 10/2008
2	Collagen Type I (Type I Collagen)IBA 02/2012 - 01/2012
2	Transforming Growth Factors (Transforming Growth Factor)IBA 02/2012 - 01/2012
2	AntioxidantsIBA 02/2012 - 11/2010
2	Thioctic Acid (Lipoic Acid)IBA 02/2012 - 11/2010
1	collagen-glycosaminoglycan copolymerIBA 07/2021
1	Ophthalmic Solutions (Eye Drops)IBA 07/2021
1	Contrast MediaIBA 01/2021
1	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 11/2015
1	CalciumIBA 11/2015
1	Pharmaceutical PreparationsIBA 01/2014
1	Proteins (Proteins, Gene)FDA Link 01/2014
1	NF-E2-Related Factor 2IBA 01/2014
1	scoparoneIBA 01/2013
1	AgarIBA 01/2013
1	Adenosine Triphosphate (ATP)IBA 02/2012
1	Caspase 9IBA 02/2012
1	sulforaphaneIBA 02/2012
1	Cytochromes c (Cytochrome c)IBA 02/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2012
1	Fibronectins (Fibronectin)IBA 01/2012
1	Genetic Markers (Genetic Marker)IBA 05/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2011
1	Calcium OxalateIBA 05/2011
1	Calcium-Sensing ReceptorsIBA 05/2011
1	p38 Mitogen-Activated Protein KinasesIBA 11/2010
1	RNA (Ribonucleic Acid)IBA 11/2010
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 04/2010
1	ectonucleotide pyrophosphatase phosphodiesterase 1IBA 04/2010
1	OsteoprotegerinIBA 04/2010
1	ClusterinIBA 10/2009
1	PyransIBA 04/2009
1	NAD (NADH)IBA 04/2009
1	beta-lapachoneIBA 04/2009
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009
1	Serine (L-Serine)FDA Link 10/2008
1	Tyrosine (L-Tyrosine)FDA Link 10/2008
1	Oxygen (Dioxygen)IBA 07/2007
1	OzoneIBA 07/2007
1	cyclopentenoneIBA 03/2007
1	Estrogen Receptor alphaIBA 03/2007
1	PPAR gammaIBA 03/2007
1	NucleotidesIBA 07/2004
1	Amino Acids FDA Link 05/2004
1	Orphan Nuclear ReceptorsIBA 05/2004

Therapy/Procedure

2	Therapeutics 04/2009 - 07/2007
1	Osteotomy 07/2013
1	Ligation 02/2012
1	Stents 11/2010
1	Drug-Eluting Stents 11/2010
1	Electroacupuncture 01/2010
1	Aftercare (After-Treatment) 07/2007